TET2 and brain neoplasm: It has been well established that various mutations of Tet2 lead to the development of myeloid malignancy28, 43, 44, thus the Tet2 loss-of-function mutations or deletions in aNSCs could link aberrant neurogenesis to the development of brain tumours such as gliomas45.